Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)*

Interleukin-6 (IL-6) activates cells by binding to the membrane-bound IL-6 receptor (IL-6R) and subsequent formation of a glycoprotein 130 homodimer. Cells that express glycoprotein 130, but not the IL-6R, can be activated by IL-6 and the soluble IL-6R which is generated by shedding from the cell surface or by alternative splicing. Here we show that cholesterol depletion of cells with methyl-β-cyclodextrin increases IL-6R shedding independent of protein kinase C activation and thus differs from phorbol ester-induced shedding. Contrary to cholesterol depletion, cholesterol enrichment did not increase IL-6R shedding. Shedding of the IL-6R because of cholesterol depletion is highly dependent on the metalloproteinase ADAM17 (tumor necrosis factor-α-converting enzyme), and the related ADAM10, which is identified here for the first time as an enzyme involved in constitutive and induced shedding of the human IL-6R. When combined with protein kinase C inhibition by staurosporine or rottlerin, breakdown of plasma membrane sphingomyelin or enrichment of the plasma membrane with ceramide also increased IL-6R shedding. The effect of cholesterol depletion was confirmed in human THP-1 and Hep3B cells and in primary human peripheral blood monocytes, which naturally express the IL-6R. For decades, high cholesterol levels have been considered harmful. This study indicates that low cholesterol levels may play a role in shedding of the membrane-bound IL-6R and thereby in the immunopathogenesis of human diseases.

[1]  F. Fahrenholz,et al.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. , 2003, Blood.

[2]  Stefan Rose-John,et al.  The human interleukin‐6 (IL‐6) receptor exists as a preformed dimer in the plasma membrane , 2003, FEBS letters.

[3]  G. Morgan,et al.  Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells* , 2003, The Journal of Biological Chemistry.

[4]  K. Kallen The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. , 2002, Biochimica et biophysica acta.

[5]  B. de Strooper,et al.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. , 2002, Human molecular genetics.

[6]  AndrewJ. S. Coats MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[7]  P. Sehgal,et al.  Cytokine Signaling , 2002, The Journal of Biological Chemistry.

[8]  L. Sandirasegarane,et al.  Ceramide-induced Inhibition of Akt Is Mediated through Protein Kinase Cζ , 2002, The Journal of Biological Chemistry.

[9]  I. Charo,et al.  Tumor Necrosis Factor- (cid:1) -converting Enzyme Mediates the Inducible Cleavage of Fractalkine* , 2022 .

[10]  F. Maxfield,et al.  Cholesterol depletion induces large scale domain segregation in living cell membranes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Y. Hannun,et al.  Ceramide inhibition of NF‐κB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl‐terminal phosphorylation of PKC for the ceramide response , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  C. Blobel,et al.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.

[13]  B. Strooper,et al.  The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. , 2001, The Journal of biological chemistry.

[14]  S. Soltoff Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. , 2001, The Journal of biological chemistry.

[15]  M. Amiot,et al.  Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells. , 2001, The Biochemical journal.

[16]  K. Yano,et al.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study , 2001, The Lancet.

[17]  T. S. Wilkinson,et al.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.

[18]  Y. Shoenfeld,et al.  Atherosclerosis as an infectious, inflammatory and autoimmune disease , 2001 .

[19]  A. M. Lefer,et al.  Simvastatin Exerts Both Anti-inflammatory and Cardioprotective Effects in Apolipoprotein E—Deficient Mice , 2001, Circulation.

[20]  B. Wolozin A fluid connection: Cholesterol and Aβ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Gerken,et al.  Possible role of human interleukin‐6 and soluble interleukin‐6 receptor in hepatitis B virus infection , 2001, Journal of viral hepatitis.

[22]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Taubes The Soft Science of Dietary Fat , 2001, Science.

[25]  R. Zinkernagel,et al.  Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 , 2001, The Journal of Immunology.

[26]  S. Rose-John,et al.  Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. , 2001, The Biochemical journal.

[27]  Simon A. Jones,et al.  The soluble interleukin 6 receptor: mechanisms of production and implications in disease , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Y. Chao,et al.  Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[29]  H. Lemke,et al.  CD30 Shedding from Karpas 299 Lymphoma Cells Is Mediated by TNF-α-Converting Enzyme1 , 2000, The Journal of Immunology.

[30]  E. Gulbins,et al.  Streptolysin O‐permeabilized granulocytes shed L‐selectin concomitantly with ceramide generation via neutral sphingomyelinase , 2000, Journal of leukocyte biology.

[31]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[32]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[33]  D. Small,et al.  Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .

[34]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[35]  A. Maelicke,et al.  Production of Ceramides Causes Apoptosis during Early Neural Differentiation in Vitro * , 2000, The Journal of Biological Chemistry.

[36]  R. Black,et al.  Stimulation-induced Down-regulation of Tumor Necrosis Factor-α Converting Enzyme* , 2000, The Journal of Biological Chemistry.

[37]  S. Rose-John,et al.  Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. , 2000, European journal of biochemistry.

[38]  M. Neurath,et al.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo , 2000, Nature Medicine.

[39]  J. Buxbaum,et al.  Tumor Necrosis Factor-α-converting Enzyme Is Required for Cleavage of erbB4/HER4* , 2000, The Journal of Biological Chemistry.

[40]  C. Blobel,et al.  Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). , 2000, The Biochemical journal.

[41]  A Cumano,et al.  A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. , 2000, Molecular cell.

[42]  R. Doms,et al.  Protein Kinase C-dependent α-Secretase Competes with β-Secretase for Cleavage of Amyloid-β Precursor Protein in the Trans-Golgi Network* , 2000, The Journal of Biological Chemistry.

[43]  S. Rose-John,et al.  Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. , 1999, Journal of immunology.

[44]  P. Galle,et al.  New developments in IL-6 dependent biology and therapy: where do we stand and what are the options? , 1999, Expert opinion on investigational drugs.

[45]  S. Rose-John,et al.  A role for the immunoglobulin-like domain of the human IL-6 receptor. Intracellular protein transport and shedding. , 1999, European journal of biochemistry.

[46]  S. Rose-John,et al.  Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. , 1998, Blood.

[47]  David C. Lee,et al.  An essential role for ectodomain shedding in mammalian development. , 1998, Science.

[48]  Joseph D. Buxbaum,et al.  Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor* , 1998, The Journal of Biological Chemistry.

[49]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[50]  S. Bhakdi,et al.  Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[51]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Trapp,et al.  Caveolae, Plasma Membrane Microdomains for α-Secretase-mediated Processing of the Amyloid Precursor Protein* , 1998, The Journal of Biological Chemistry.

[53]  G. Ciliberto,et al.  Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. , 1997, Immunity.

[54]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[55]  N. Hooper,et al.  Membrane protein secretases. , 1997, The Biochemical journal.

[56]  R. Black,et al.  A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. , 1995, Journal of immunology.

[57]  J. Slotte,et al.  Localization of cholesterol in sphingomyelinase-treated fibroblasts. , 1995, The Biochemical journal.

[58]  M. Waki,et al.  Soluble interleukin‐6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism , 1994, European journal of immunology.

[59]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[60]  P. Heinrich,et al.  The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. , 1994, Journal of immunology.

[61]  K. Kallen,et al.  Synthesis of surface sphingomyelin in the plasma membrane recycling pathway of BHK cells. , 1994, Biochimica et biophysica acta.

[62]  K. Kallen,et al.  Monensin inhibits synthesis of plasma membrane sphingomyelin by blocking transport of ceramide through the Golgi: evidence for two sites of sphingomyelin synthesis in BHK cells. , 1993, Biochimica et biophysica acta.

[63]  P. Heinrich,et al.  The soluble interleukin‐6 receptor is generated by shedding , 1993, European journal of immunology.

[64]  K. Kallen,et al.  Effects of brefeldin A on sphingomyelin transport and lipid synthesis in BHK21 cells. , 1993, The Biochemical journal.

[65]  P. Heinrich,et al.  Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. , 1992, Biochemical and biophysical research communications.

[66]  D. Cosman,et al.  Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor , 1991, Cell.

[67]  G. Hensel,et al.  Protein kinase C-independent activation of nuclear factor kappa B by tumor necrosis factor. , 1990, The Journal of biological chemistry.

[68]  W. V. van Blitterswijk,et al.  Quantitative contributions of cholesterol and the individual classes of phospholipids and their degree of fatty acyl (un)saturation to membrane fluidity measured by fluorescence polarization. , 1987, Biochemistry.

[69]  W. J. Blitterswijk,et al.  Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. , 1981 .